TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a ...

CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...

The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx have faced growing criticism over their role in high drug costs — including a recent lawsuit from the ...

In 2023, about 80% of all prescription drug claims in the U.S. were processed by only three companies. VC-backed Rightway CEO ...

Texas Attorney General Ken Paxton alleges several major manufacturers and pharmacy benefit managers have driven the costs of ...

The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin.

Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.

CVS has been reviewing its strategic options for months as rising medical costs in its Aetna insurance arm weigh on the ...

Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health ...

With CVS ( CVS) reportedly weighing a breakup of its vertical businesses, the healthcare industry could be marching toward ...

CVS Health (CVS) business segment earns attention as multiple reports indicated on Monday that the healthcare conglomerate is ...

CVS Health Corporation (CVS) is set to cut approximately 2,900 jobs as part of a multiyear, $2 billion cost-saving initiative ...